Table 1. AUC and Bioavailability of Intravenously (i.v.) or Orally (p.o.) Injected NMT^a.

route of administration	AUC0–180min (min·μg/mL)	bioavailability (%)
i.v. (0.5 mg/kg BW)	54.0 ± 3.6
p.o. (0.5 mg/kg BW)	51.9 ± 4.1	96.1
p.o. (5 mg/kg BW)	315 ± 27.9	58.0

^aData are presented as means ± standard errors of measurements from three mice per dosing group.